Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kestra Med Technologies Ltd SHS | 1,645,893 | 1,645,893 | 0 | $27.29M | $39.11M | 17.59% | +$11.82M |
| Beta Bionics, Inc.(BBNX) | 1,988,287 | 1,920,125 | -68,162 | $28.95M | $38.15M | 17.16% | +$9.20M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 3,289,661 | +3,289,661 | $0 | $38.09M | 17.13% | +$38.09M |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | $20.48M | $34.81M | 15.66% | +$14.33M |
| Nuvation Bio Inc.CL A(NUVB) | 11,042,728 | 8,831,089 | -2,211,639 | $21.53M | $32.68M | 14.69% | +$11.14M |
| Upstream Bio, Inc.(UPB) | 2,036,293 | 1,356,293 | -680,000 | $22.36M | $25.51M | 11.47% | +$3.15M |
| ImageneBio, Inc.(IMA) | 0 | 455,361 | +455,361 | $0 | $3.71M | 1.67% | +$3.71M |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | $1.92M | $3.60M | 1.62% | +$1.68M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $2.30M | $3.00M | 1.35% | +$691.9K |
| Alumis Inc. | 653,223 | 653,223 | 0 | $1.96M | $2.61M | 1.17% | +$646.7K |
| Replimune Group, Inc.(REPL) | 1,975,203 | 248,672 | -1,726,531 | $18.35M | $1.04M | 0.47% | -$17.31M |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 321,502 | 89,702 | -231,800 | $273.0K | $63.4K | 0.03% | -$209.5K |
| Ikena Oncology | 2,249,123 | 0 | -2,249,123 | $3.01M | $0 | — | -$3.01M |
| Immunic, Inc.(IMUX) | 1,788,160 | 0 | -1,788,160 | $1.25M | $0 | — | -$1.25M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,184,636 | 0 | -1,184,636 | $4.76M | $0 | — | -$4.76M |